2025年疫苗市场动态观察:13价肺炎球菌结合疫苗竞争加剧与行业趋势解析

报告大厅
Jun 23, 2025

中国报告大厅网讯,(基于国家药监局及行业公开信息统计)  当前全球疫苗产业正经历技术迭代与市场竞争的双重变革。在中国,随着创新疫苗研发加速和公共卫生需求升级,低龄自费疫苗市场竞争白热化,而13价肺炎球菌结合疫苗作为重要细分领域,其发展路径折射出行业整体趋势。2025年6月,康希诺生物宣布旗下优佩欣获批上市,标志着国内该品类竞争格局进一步深化,也预示着疫苗企业正通过差异化设计、国际化布局和产品组合...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10